Pomerantz LLP Calls Attention to Class Action Against MoonLake Immunotherapeutics – MLTX
NEW YORK CITY, NY / ACCESS Newswire / November 9, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against MoonLake Immunotherapeutics ("Moonlake" or the "Company") (NASDAQ:MLTX). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged […]